ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1411

CD8+ T Cell Subsets and Immune Checkpoint Profiles in Ankylosing Spondylitis Implicate Dysregulation of Cytotoxic T Lymphocytes (CTL)

Michael Tang1, Zoya Qaiyum2, Melissa Lim1 and Robert Inman2, 1UNIVERSITY HEALTH NETWORK, TORONTO, Canada, 2University Health Network, Toronto, ON, Canada

Meeting: ACR Convergence 2020

Keywords: Ankylosing spondylitis (AS), autoimmune diseases, Genomics and Proteomics, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Ankylosing Spondylitis (AS) is characterized by chronic inflammation which underlies the pain and precedes spinal ankylosis. The strongest genetic association with AS is the HLA-B27, implicating involvement of CD8+ cytotoxic T cells (CTL) in AS pathogenesis. To date, the CTL compartment that underlies AS inflammation has yet to be fully defined. Our lab recently reported altered cytotoxicity profiles in CTL from AS patients, suggesting that dysregulated CTL with a cytotoxic phenotype are recruited to the joints. These findings suggest a central role of dysregulated CTLs in AS pathogenesis, warranting further investigation. Here we sought to characterize CTL subsets and immune checkpoint (IC) expression on CTL from patients with AS.

Methods: We performed immunophenotyping of peripheral blood mononuclear cells (PBMCs) and synovial fluid mononuclear cells (SFMCs) by flow cytometry. A 21- marker mass cytometry time-of-flight (CyTOF) panel is currently being developed to comprehensively assess the CTL compartment in AS patients.

Results: We identified a sub-cohort of AS patients with an enriched population of terminally differentiated memory CTL (up to 46.2% of all CD8+ T cells, expressing CD45RA+CCR7–) in the periphery and elevated expression of the IC molecules PD-1 (18.3% vs 10.2% of total CD8+ T cells) & TIGIT (17.3% vs. 4.4% of total CD8+ T cells) on AS CTL compared to healthy controls. Effector memory CTL (CD45RA–CCR7–) were highly enriched in the SF. PD-1 expression is also highly upregulated in the synovial CTL (up to 75% of CD8+ T cells), suggesting local immune activation. Despite PD-1 upregulation in these CTL subsets, evidence of immune exhaustion, as assessed by EOMES expression, was not found.

Conclusion: We demonstrate that CTL from AS patients are highly activated, and are characterized by a distinct immune phenotype which implicates an intrinsic CTL dysregulation in AS pathogenesis.


Disclosure: M. Tang, None; Z. Qaiyum, None; M. Lim, None; R. Inman, Abbvie, 5, Amgen, 5, Janssen, 5, Lilly, 5, Novartis, 5.

To cite this abstract in AMA style:

Tang M, Qaiyum Z, Lim M, Inman R. CD8+ T Cell Subsets and Immune Checkpoint Profiles in Ankylosing Spondylitis Implicate Dysregulation of Cytotoxic T Lymphocytes (CTL) [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/cd8-t-cell-subsets-and-immune-checkpoint-profiles-in-ankylosing-spondylitis-implicate-dysregulation-of-cytotoxic-t-lymphocytes-ctl/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cd8-t-cell-subsets-and-immune-checkpoint-profiles-in-ankylosing-spondylitis-implicate-dysregulation-of-cytotoxic-t-lymphocytes-ctl/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology